Infertility Treatment Market Report 2020; Forecasts to 2024 - Key Players are The Cooper Companies, Cook Medical, Vitrolife, Ferring Pharmaceuticals, IVFtech, FUJIFILM Irvine Scientific, and Merck

DUBLIN, Jan. 22, 2020 /PRNewswire/ -- The "Infertility Treatment Market - Global Outlook and Forecast 2019-2024" report has been added to's offering.

    --  This analysis of the infertility treatment market provides sizing and
        growth opportunities for the forecast period 2019-2024.
    --  Provides comprehensive insights on the latest industry trends, forecast,
        and growth drivers in the market.
    --  Includes a detailed analysis of growth drivers, challenges, and
        investment opportunities.
    --  Delivers a complete overview of segments and the regional outlook of the
        infertility treatment market.
    --  Offers an exhaustive summary of the vendor landscape, competitive
        analysis, and key strategies to gain competitive advantage.

The Global Infertility Treatment Market is Expected to Grow at a CAGR of Over 6% During the Forecast Period 2018-2024.

The growing prevalence of infertility among men and women is increasing the demand for sterility treatment globally. Factors such as delayed parenthood, obesity, sexually transmitted infections (STIs), and aging is increasing sterility incidences among married couples worldwide.

The increasing acceptance of advanced and sophisticated medical care options such as ART and IVF is likely to drive the market. The globalization of healthcare facilities and the increasing popularity of medical tourism, especially fertility tourism, encourage several couples to travel abroad to seek state-of-the-art medical care options. The reimbursement coverage is also improving globally, and many countries cover fertility treatment as part of respective public health coverage programs

The following factors are likely to contribute to the growth of the infertility treatment market during the forecast period:

    --  Increasing Prevalence of Infertility
    --  Growing Number of Obesity Cases
    --  Increasing Number of Facilities offering Fertility Services
    --  Increasing Financial Assistance Programs

    --  Growing popularity for Fertility Tourism

Infertility Treatment Market: Segmentation

This research report includes detailed segmentation by product, procedure, end-user, cause, and geography.

Treatment by drugs has been dominating the infertility treatment market because it is a cost-effective measure and is considered to be the first choice among people to be treated. The acceptance of gonadotropin drugs for treatment is driving the segment significantly and is likely to witness steady growth during the forecast period. However, the surge in the prevalence of sterility, advances IVF devices technology, the increasing trend of delayed pregnancies, and the growth in disposable income are the major factors driving the infertility treatment devices market.

Globally, the IVF treatments are witnessing an improvement in overall success rates majorly due to the availability of a broad range of culture media. The consumables segment is rapidly increasing due to the increasing effectiveness of ART procedures and surgical interventions that create huge demand for consumables and is expected to grow by 2024.

The medication segment is the largest contributor due to a wide range and usage. The increasing approval of fertility services and cultural shifts has led to a high demand for medication and treatments. The awareness of sterility treatment has increased over time, thereby reducing the reluctance of people to opt for medication. ART is the fastest growing procedure on account of the high acceptance of this treatment because of the improvement in success rate and advanced techniques to cure sterility. The favorable financial support for ART procedures in both developed and emerging countries is another factor contributing to the growth. However, the segment is likely to witness hindrance due to the high cost of ART procedures.

The fertility clinics dominate the market due to the high success rate of fertility services and IVF clinics. The number of fertility services is expanding across the globe. These clinics occupy the largest share in the infertility treatment market owing to the availability and accessibility of different services such as IVF programs, egg donation, ICSI, IMSI, and other services. The segment is projected to hold the highest share during the forecast period due to the constant rise in clinics and increasing partnerships of clinics with fertile consultants and experts.

The female infertility segment is contributing significantly to the market due to the high prevalence of female infertility globally. The increase in the target pool of female patients and the growing number of dedicated fertility clinics are the major factors driving the growth of the segment. The prevalence of male sterility is increasing worldwide due to changes in lifestyle patterns, an increase in the consumption of alcohol and smoking, and an increase in the prevalence of obesity. All these factors affect sperm counts and their quality, thereby increasing the occurrence among men.

Europe is the major region, which is leading the market and is expected to bolster its dominance during the forecast period because the region is going through a phase of reduction in population and is seriously considering tackling this sociological phenomenon. The demand for fertility services is increasing rapidly in North America due to the growing prevalence of sterility, the presence of the aging population and the high occurrence of obesity. These factors are likely to generate significant demand for fertility services in the future.

APAC is growing at a steady pace owing to the shifting mean age among women during their first childbirth and the increasing sterility among people in developing countries. Latin America is witnessing a rise in sterility among men and women and decreasing fertility rates in the population, which is likely to increase the demand for fertility services. MEA faces a low healthcare facility, a lack of specialized health care professionals, and inadequate awareness of fertility medical care. However, with the growing awareness and development of advanced technology, the region is expected to drive the infertility treatment market in the region.

Insights by Vendors

There are a few global and several local and regional vendors offering medicines, devices, and equipment for treatment. The fertility drugs market is highly concentrated with key pharmaceuticals accounting for commendable shares. However, the other fertility drugs market is highly fragmented with many local and domestic companies are offering a wide array of low-cost drugs in their respective countries. The market is competitive due to the availability of several low-cost drugs. Companies offering fertility drugs are registering impressive growth rates for their products due to the increased uptake of these drugs.

Key Topics Covered

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.2 Market Segmentation by Infertility Cause
4.4.3 Market Segmentation by Procedure
4.4.4 Market Segmentation by End-user
4.4.5 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Infertility: An Overview
7.1.1 Symptoms of Infertility
7.1.2 Causes of Infertility
7.1.3 Infertility Treatment
7.2 Infertility Treatment: Global Market Snapshot
7.2.1 Overview

8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Increasing Prevalence of Infertility
8.1.2 Rising Number of Obesity Cases
8.1.3 Increasing Acceptance of ART Procedures
8.1.4 Increasing Number of Facilities Offering Fertility Services
8.2 Market Growth Restraints
8.2.1 High Cost of Infertility Treatment
8.2.2 Lack of Standardized Government Regulations on Infertility Treatment
8.2.3 Ethical Challenges Related to Infertility Treatment
8.2.4 Limitations & Risks Associated with Infertility Treatment
8.3 Market Opportunities & Trends
8.3.1 Financial Assistance Programs & Employer Benefits for Infertility Treatment
8.3.2 Growing Popularity of Fertility/Reproductive Tourism
8.3.3 Technological Advancements & Innovations
8.3.4 Acceptance of Infertility Treatment in Single Parents & Same-Sex Couples

9 Global Infertility Treatment Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis

10 By Product
10.1 Market Snapshot & Growth Engine
10.2 Market Overview

11 Infertility Treatment by Drugs
11.1 Market Overview
11.2 Gonadotropins
11.3 Other Drugs
11.4 Infertility Drugs: Market Segmentation by Region

12 Infertility Treatment by Devices
12.1 Market Overview
12.2 Equipment
12.3 Media
12.4 Consumables & Accessories
12.5 Infertility Treatment Devices: Segmentation by Region

13 By Cause
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Female Infertility
13.4 Male Infertility
13.5 Other Types of Infertility

14 By Procedure
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Medication
14.4 Assisted Reproductive Treatment
14.5 Surgical Intervention

15 By End-user
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Fertility Clinics
15.4 Hospitals
15.5 Gynecology & Urology Clinics
15.6 Other End-users

16 By Geography
16.1 Market Snapshot & Growth Engine
16.2 Market Overview

17 Europe

18 North America


20 Latin America

21 Middle East & Africa

22 Competitive Landscape
22.1 Competition Overview
22.2 Vendors Market Share Analysis
22.2.1 The Cooper Companies
22.2.2 Cook Medical
22.2.3 Vitrolife in Infertility Treatment Market
22.2.4 Ferring Pharmaceuticals
22.2.5 Merck KGaA
22.2.6 IVFtech in Infertility Treatment Market

23 Key Company Profiles
23.1 The Cooper Companies
23.1.1 Business Overview
23.1.2 Major Product Offerings
23.1.3 Key Strengths
23.1.4 Key Strategies
23.1.5 Key Opportunities
23.2 Cook Medical
23.3 Vitrolife
23.4 Ferring Pharmaceuticals
23.5 IVFtech
23.6 FUJIFILM Irvine Scientific
23.7 Merck KGaA

24 Other Prominent Vendors
24.1 Abbott
24.1.1 Business Overview
24.1.2 Major Product Offerings
24.2 Sanofi
24.3 Salix Pharmaceuticals
24.4 Microtech IVF
24.5 Novartis
24.6 Hamilton Thorne
24.7 Merck Co.
24.8 Thermo Fisher Scientific
24.9 INVO Bioscience
24.10 MedGyn Products
24.11 SOMATEX Medical Technologies
24.12 Carl Zeiss

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets